Helix BioMedix, Inc., a biopharmaceutical company specializing in peptides, recently announced the promotion of Robin L. Carmichael to the position of chief executive officer in addition to her current role as president. She will continue as a member of the company’s Board of Directors. Carmichael will be responsible for all aspects of management of Helix BioMedix including profits and losses, operations, sales, marketing, business development,…